Clinical evaluation of the effect on oral administration of tarÄ? mÄ?ttirai in management of Vitiligo
Phase 2
Completed
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2019/07/020042
- Lead Sponsor
- Santhoshkumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
The patient attending to the OPD will be screened for the following symptoms and will be included in the study
Primary symptoms
1. Hypopigmented patches with hyperpigmented border without any structural changes in any part of the body surface.
2. Children who are willing to undergo blood tests for laboratory investigations
Exclusion Criteria
Tinea versicolor
Chemical leucoderma
Dermatological manifestation of leprosy
Burn scar
Pityriasis alba
Total albinism
White patches in mucous membrane
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of the hypopigmented lesions over the affected areaTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Reduction in the reccurence rate of the lesionsTimepoint: 3 months